Clinical Effect of Ampreloxetine (TD-9855) for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure

Clinical trial NCT03750552 · COMPLETED

Trial details

NCT number: NCT03750552
Sponsor: Theravance Biopharma
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Symptomatic Neurogenic Orthostatic Hypotension

Start date: 2019-01-24
Primary completion: 2021-07-21
Enrollment: 195

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.